OFFICE EVALUATION AND MANAGEMENT OF BLADDER NEOPLASMS
Open Access
- 1 November 1998
- journal article
- review article
- Published by Elsevier in Urologic Clinics of North America
- Vol. 25 (4) , 603-611
- https://doi.org/10.1016/s0094-0143(05)70051-3
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998
- A Multicenter Trial Evaluation of the Fibrin/Fibrinogen Degradation Products Test for Detection and Monitoring of Bladder CancerJournal of Urology, 1997
- Initial Evaluation of Cyfra 21-1 Diagnostic Performances as a Urinary Marker in Bladder Transitional Cell CarcinomaJournal of Urology, 1997
- Is Routine Excretory Urography Necessary at First Diagnosis of Bladder Cancer?Journal of Urology, 1997
- Urethral Recurrence in Patients with Orthotopic Ileal NeobladdersJournal of Urology, 1996
- Use of a New Tumor Marker, Urinary NMP22, in the Detection of Occult or Rapidly Recurring Transitional Cell Carcinoma of the Urinary Tract Following Surgical TreatmentJournal of Urology, 1996
- Autocrine Motility Factor Receptor as a Possible Urine Marker for Transitional Cell Carcinoma of the BladderJournal of Urology, 1996
- Results of a Multicenter Trial using the BTA Test to Monitor for and Diagnose Recurrent Bladder CancerJournal of Urology, 1995
- Superficial Bladder Cancer: Timing of Check Cystoscopies in the First YearBritish Journal of Urology, 1993
- Intravesical BCG: Current results, natural history and implicants for urothelial cancer preventionJournal of Cellular Biochemistry, 1992